Growth Metrics

Travere Therapeutics (TVTX) Net Income towards Common Stockholders (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -102.02%
Dec 31, 2024 106.78%
Sep 30, 2024 92.21%
Jun 30, 2024 -634.95%
Mar 31, 2024 93.47%
Dec 31, 2023 -100.66%
Sep 30, 2023 1,372.06%
Jun 30, 2023 59.31%
Mar 31, 2023 -48.35%
Dec 31, 2022 37.52%
Sep 30, 2022 10.90%
Jun 30, 2022 124.95%
Mar 31, 2022 106.51%
Dec 31, 2021 -149.09%
Sep 30, 2021 8.65%
Jun 30, 2021 27.56%
Mar 31, 2021 55.72%
Dec 31, 2020 -439.37%
Sep 30, 2020 13.50%
Jun 30, 2020 -3,326.24%
Mar 31, 2020 102.67%
Dec 31, 2019 17.08%
Sep 30, 2019 5.71%
Jun 30, 2019 5.55%
Mar 31, 2019 -449.66%
Dec 31, 2018 86.33%
Sep 30, 2018 -144.15%
Jun 30, 2018 -21.50%
Mar 31, 2018 -4.31%
Dec 31, 2017 0.99%
Sep 30, 2017 -34.51%
Jun 30, 2017 -19.29%
Mar 31, 2017 -28.91%
Dec 31, 2016 76.82%
Sep 30, 2016 -176.90%
Jun 30, 2016 -219.50%
Mar 31, 2016 554.27%
Dec 31, 2015 -102.34%
Sep 30, 2015 513.59%
Jun 30, 2015 -164.37%
Mar 31, 2015 236.61%
Dec 31, 2014 -61.44%
Sep 30, 2014 -252.31%
Jun 30, 2014 115.59%
Mar 31, 2014 -494.17%
Dec 31, 2013 -6.12%
Sep 30, 2013 -143.96%
Jun 30, 2013 -1.14%
Aug 31, 2012 0.26%